Co-Expression of miR155 or LSD1 shRNA Increases the Anti-Tumor Functions of CD19 CAR-T Cells

Overview of attention for article published in Frontiers in immunology, January 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (68th percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 37,702 followers.

RT @CARTTherapy: Co-Expression of miR155 or LSD1 shRNA Increases the Anti-Tumor Functions of CD19 CAR-T Cells https://t.co/G1Fdqfb9ez #CAR…

RT @CARTTherapy: Co-Expression of miR155 or LSD1 shRNA Increases the Anti-Tumor Functions of CD19 CAR-T Cells https://t.co/G1Fdqfb9ez #CAR…

Co-Expression of miR155 or LSD1 shRNA Increases the Anti-Tumor Functions of CD19 CAR-T Cells https://t.co/G1Fdqfb9ez #CART #bmtsm #CARTcell #immunotherapy #tcellrx #ICAN #CRS #CARTcells #CellTherapy @FrontImmunol

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.